المؤلفون: Sara W. Quist, Alexander V. van Schoonhoven, Stephan J. L. Bakker, Michał Pochopień, Maarten J. Postma, Jeanni M. T. van Loon, Jeroen H. J. Paulissen

المصدر: Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-16 (2023)

مصطلحات موضوعية: Cost-effectiveness-analysis, Chronic kidney disease, Type 2 diabetes, Costs, QALYs, Finerenone, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1475-2840

URL الوصول: https://doaj.org/article/f0123344ab7a47149b04a791e10d6a10